Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 3,600 shares at $4.96 ($18K) on 2009-06-12, disclosed to the SEC on 2009-06-15.
Scheduled sale ($18k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.13 | 1,100 | $6K | 31.3% |
| 2 | $4.96 | 2,500 | $12K | 68.7% |
| Total | $5.01 avg | 3,600 | $18K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |